Bay Area startup gets $49M NIH grant to study bacterium-targeting therapy in Alzheimer's – FirstWord Pharma

Written by

admin

in

  1. Bay Area startup gets $49M NIH grant to study bacterium-targeting therapy in Alzheimer’s  FirstWord Pharma
  2. Lighthouse Pharmaceuticals Receives $49.2 Million NIA Grant for Phase 2 Trial of Alzheimer’s Drug Targeting Porphyromonas Gingivalis  geneonline.com
  3. NIA funds trial of Alzheimer’s drug targeting oral health bacteria  Longevity.Technology
  4. NIA beams $49M to Lighthouse for bacteria-related Alzheimer’s disease trial  Fierce Biotech
  5. Lighthouse Pharmaceuticals Awarded $49.2 Million Grant from NIA to Advance Phase 2 study of LHP588  Pharmaceutical Executive

Continue Reading

More posts